• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Haemochromatosis.

作者信息

Crawford D H, Leggett B A, Powell L W

机构信息

Department of Gastroenterology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

出版信息

Baillieres Clin Gastroenterol. 1998 Jun;12(2):209-25. doi: 10.1016/s0950-3528(98)90131-2.

DOI:10.1016/s0950-3528(98)90131-2
PMID:9890069
Abstract

Primary, hereditary or genetic haemochromatosis is one of the most common inherited disorders in a Caucasian populations with a disease frequency of 1:300-400 and a carrier frequency of approximately 10%. The basic genetic defect remains unknown, although the haemochromatosis gene has now been cloned and is known to be a member of the MHC non-classical class I family. Many factors--environmental, genetic and non-genetic in nature--influence the degree of iron loading in affected individuals. In particular, pathological and physiological blood loss influence iron stores in haemochromatosis. The iron concentration in the liver is an important determinant of survival because a hepatic iron concentration in excess of 400 mumol/g dry weight is usually associated with cirrhosis. Patients with cirrhosis secondary to haemochromatosis are at risk of hepatocellular carcinoma. The combination of improved awareness of the disease and the appropriate use of genetic testing for the common C282Y mutation should lead to earlier diagnosis and therapy.

摘要

相似文献

1
Haemochromatosis.
Baillieres Clin Gastroenterol. 1998 Jun;12(2):209-25. doi: 10.1016/s0950-3528(98)90131-2.
2
Factors influencing disease expression in hemochromatosis.
Annu Rev Nutr. 1996;16:139-60. doi: 10.1146/annurev.nu.16.070196.001035.
3
Review article: the screening, diagnosis and optimal management of haemochromatosis.综述文章:血色素沉着症的筛查、诊断及最佳管理
Aliment Pharmacol Ther. 1997 Aug;11(4):631-9. doi: 10.1046/j.1365-2036.1997.00197.x.
4
Review article: haemochromatosis.综述文章:血色素沉着症
Aliment Pharmacol Ther. 2002 Dec;16(12):1963-75. doi: 10.1046/j.1365-2036.2002.01371.x.
5
Hereditary haemochromatosis: diagnosis and management in the gene era.遗传性血色素沉着症:基因时代的诊断与管理
Liver. 1999 Apr;19(2):73-80. doi: 10.1111/j.1478-3231.1999.tb00014.x.
6
Current concepts in rational therapy for haemochromatosis.
Drugs. 1991 Jun;41(6):875-82. doi: 10.2165/00003495-199141060-00005.
7
John's story - living with hereditary haemochromatosis.约翰的故事——与遗传性血色素沉着症相伴生活。
Rural Remote Health. 2019 May;19(2):4844. doi: 10.22605/RRH4844. Epub 2019 May 5.
8
[Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].[瑞士遗传性血色素沉着症患者中HFE基因突变频率及基因型-表型相关性]
Schweiz Med Wochenschr. 2000 Aug 8;130(31-32):1112-9.
9
Haemochromatosis in the new millennium.
J Hepatol. 2000;32(1 Suppl):48-62. doi: 10.1016/s0168-8278(00)80415-8.
10
[Importance of hereditary haemochromatosis in the care of diabetes mellitus].[遗传性血色素沉着症在糖尿病护理中的重要性]
Orv Hetil. 2007 Jan 21;148(3):111-5. doi: 10.1556/OH.2007.27901.

引用本文的文献

1
Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases.转铁蛋白的病理生理学方面——一种潜在的基于纳米的药物递送信号分子,用于多种疾病的治疗靶点
Front Pharmacol. 2024 Mar 4;15:1342181. doi: 10.3389/fphar.2024.1342181. eCollection 2024.
2
Duodenal expression of iron transport molecules in untreated haemochromatosis subjects.未经治疗的血色素沉着症患者十二指肠中铁转运分子的表达
Gut. 2003 Jul;52(7):953-9. doi: 10.1136/gut.52.7.953.